Stocks with Implied Volatility Movement
- ByInvesting.com-
Symbol | Exchange | Currency |
---|
Aytu BioPharma, Inc. (AYTU) today reported financial results for its fiscal 2022 third quarter, ended March 31, 2022 and outlined its key strategic priorities."In our fiscal third...
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Financials, Technology and Oil & Gas sectors led shares higher. At the close in NYSE, the Dow...
bluebird Inc. BLUE announced new data from ongoing phase III studies onits investigational betibeglogene autotemcel (formerly LentiGlobin for β-thalassemia gene therapy). The...
Aytu BioScience, Inc. (NASDAQ:AYTU) was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more...
It is widely-known that global markets went berserk in the past month due to the increasing coronavirus scare. The confirmed cases crossed 3,80,000 while death toll topped 16,500...
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Neutral | Sell | Strong Sell | Strong Sell |
Technical Indicators | Buy | Sell | Strong Sell | Strong Sell | Strong Sell |
Summary | Buy | Neutral | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
41.14 | 41.17 | 40.71 | -0.02 | -0.05% | 1.65M | NYSE | |||
7.46 | 7.63 | 7.42 | -0.28 | -3.68% | 3.77M | NYSE | |||
135.45 | 137.60 | 135.17 | -3.32 | -2.39% | 1.56M | NYSE | |||
3.42 | 3.48 | 3.35 | -0.15 | -4.20% | 74.00K | NASDAQ | |||
2.94 | 3.02 | 2.815 | -0.030 | -1.01% | 44.70K | NYSE | |||
29.39 | 29.73 | 29.26 | -0.44 | -1.48% | 8.53M | NYSE | |||
22.60 | 22.86 | 22.48 | -0.36 | -1.57% | 4.61M | NYSE | |||
3.54 | 3.54 | 3.54 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
2.10 | 2.15 | 2.10 | -0.10 | -4.77% | 13.48K | OTC Markets | |||
5.825 | 5.895 | 5.825 | -0.255 | -4.19% | 26.89K | OTC Markets | |||
49.15 | 49.44 | 48.73 | +0.57 | +1.17% | 15.25M | NYSE | |||
1.07 | 1.11 | 0.97 | -0.05 | -4.46% | 68.45K | NASDAQ | |||
16.66 | 16.66 | 16.49 | -0.36 | -2.12% | 943.00 | OTC Markets | |||
6.00 | 6.00 | 6.00 | -0 | -1.22% | 76.80K | OTC Markets | |||
48.01 | 60.00 | 24.81 | +32.32 | +205.99% | 34.96M | NASDAQ |